Aclara BioSciences Inc., of Mountain View, Calif., added Dennis Harris as senior vice president, research and development.

Advanced Cell Technology Inc., of Worcester, Mass., added Raymond Page, Tanja Dominko, Teruhiko Wakayama and Tony Perry to its scientific team.

Aradigm Corp., of Hayward, Calif., appointed Stan Benson and Igor Gonda to its board.

Argonaut Technologies Inc., of San Carlos, Calif., promoted Lissa Goldenstein to president and chief operating officer.

Atlantic Technology Ventures Inc., of New York, appointed Frederic Zotos as CEO.

Atrix Laboratories Inc., of Fort Collins, Colo., promoted Charles Cox to senior vice president of corporate development.

Avidex Ltd., of Oxford, UK, appointed Hugh Penfold head of business development.

Biogen Inc., of Cambridge, Mass., appointed David Buckley executive vice president, technical operations.

BioStratum Inc., of Research Triangle Park, N.C., elected Thomas D¿Alonzo and Paul Marks to its board.

Cephalon Inc., of West Chester, Pa., added Robert Grupp as vice president of corporate communications.

EluSys Therapeutics Inc., of Pine Brook, N.J., added Cynthia Beach as vice president of business development and George Spitalny as vice president of research and development.

eMedsecurities Inc., of New York, appointed Vanessa Burgess head of investment banking.

emerGen Inc., of Salt Lake City, added Jeffrey Williams as vice president, corporate development and strategy.

France Biotech, of Paris, the French biotechnology industry association, elected Philippe Pouletty as president.

Ganeden Biotech Inc., of Cleveland, appointed Raymond Lamy its first director for clinical and regulatory affairs.

Genomic Solutions Inc., of Ann Arbor, Mich., appointed Christine Ethier vice president for international business.

Hyseq Inc., of Sunnyvale, Calif., added Peter Garcia as senior vice president and chief financial officer and Linda Fitzpatrick as senior vice president of human resources.

ImClone Systems Inc., of New York, added Lily Lee as vice president, regulatory and biostatistics.

Incara Pharmaceuticals Corp., of Research Triangle Park, N.C., elected Eugene McDonald to its board.

InforMax Inc., of Bethesda, Md., named Patrick Blake vice president and managing director of Europe, Middle East and Africa operations.

Interneuron Pharmaceuticals Inc., of Lexington, Mass., appointed William Boni vice president, corporate communications.

No Comments